Lifecore Biomedical Inc (LFCR) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Lifecore Biomedical Inc   (NASDAQ: LFCR)
 

Lifecore Biomedical Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Lifecore Biomedical Inc inventory turnover ratio, the Lifecore Biomedical Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 2.76 in the first quarter 2026, a new company high. Average inventory processing period, for the Lifecore Biomedical Inc in Mar 31 2026 quarter, has decreased to 132 days, compare to 139 days, in the Sep 30 2025 quarter.

Within Healthcare sector 144 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 827 in the first quarter 2026, to 1134.

LFCR Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Lifecore Biomedical Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LFCR Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Sep 30 2025)
I. Quarter		 (May 25 2025)
IV. Quarter		 (Feb 23 2025)
III. Quarter		 (Nov 24 2024)
II. Quarter
Y / Y Inventory Growth -28.2 % -18.83 % -19.23 % -12.79 % -5.39 %
Y / Y Cost of Sales Growth -14.29 % 21.05 % 4.55 % 8.7 % 5 %
Inventory Turnover Ratio (TTM) 2.76 2.63 2.38 2.24 2.12
LFCR's Total Ranking # 1134 # 827 # 1105 # 84 #
Average inventory processing period 132 139 153 163 172
Seq. Inventory Growth -16.7 % 4.68 % -6.66 % -11.78 % -5.83 %
Seq. Cost of Sales Growth -21.74 % 0 % -8 % 19.05 % 10.53 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 36
Healthcare Sector # 145
Overall Market # 1134

Inventory Turnover Ratio Statistics
High Average Low
2.76 1.91 0.53
(Mar 31 2026)   (Aug 28 2022)



LFCR Company Profile >> Back to LFCR Efficiency Comparisons >> Compare LFCR Inventory Turnover Ratio to its Competitors

Financial Statements
Lifecore Biomedical Inc 's Inventories $ 28 Millions Visit LFCR's Balance sheet
Lifecore Biomedical Inc 's Cost of Revenues TTM $ 89 Millions Visit LFCR's Income Statement
What are LFCR's Sales? Visit LFCR's Sales by Segment

Other Inventory Turnover Ratios
Lifecore Biomedical Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LFCR's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LFCR's Competitors
Inventory Turnover Ratio for LFCR's Suppliers
Inventory Turnover Ratio for LFCR's Customers

You may also want to know
LFCR's Sales Growth Rates LFCR's Pe Price to earnings ratio LFCR's Receivables Turnover Ratio LFCR's Stock Quote
LFCR's Net Income Growth Rates LFCR's Ps Price to Sales ratio LFCR's Sales per Employee LFCR's Asset Turnover Ratio
LFCR's Net Margin LFCR's Pb Price to Book ratio LFCR's Financial Strength Ratios LFCR's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Myriad Genetics Inc   8.35 $ 248.000  Millions$ 30  Millions
Pulse Biosciences Inc   8.08 $ 0.909  Millions$ 0  Millions
Castle Biosciences Inc   7.97 $ 75.178  Millions$ 9  Millions
Moderna Inc   7.96 $ 1,733.000  Millions$ 218  Millions
Carlsmed Inc   7.95 $ 12.557  Millions$ 2  Millions
Inogen Inc   7.80 $ 195.741  Millions$ 25  Millions
Cardiff Lexington Corporation  7.70 $ 4.159  Millions$ 1  Millions
Novavax inc   7.67 $ 89.620  Millions$ 12  Millions
Prophase Labs Inc   7.64 $ 2.361  Millions$ 0  Millions
Bellevue Life Sciences Acquisition Corp  7.62 $ 1.986  Millions$ 0  Millions
Lifemd Inc   7.60 $ 24.000  Millions$ 3  Millions
Charles River Laboratories International inc   7.56 $ 2,346.239  Millions$ 310  Millions
Adaptive Biotechnologies Corporation  7.43 $ 73.088  Millions$ 10  Millions
Puma Biotechnology Inc   7.19 $ 58.025  Millions$ 8  Millions
Fonar Corporation  7.06 $ 19.685  Millions$ 3  Millions
Carlisle Companies Incorporated  6.71 $ 3,206.100  Millions$ 478  Millions
Hims and Hers Health Inc   6.58 $ 670.000  Millions$ 102  Millions
Vanda Pharmaceuticals Inc   6.54 $ 12.682  Millions$ 2  Millions
Twist Bioscience Corporation  6.50 $ 196.251  Millions$ 30  Millions
Phathom Pharmaceuticals Inc   6.48 $ 30.871  Millions$ 5  Millions
Precision Optics Corporation Inc   6.47 $ 24.932  Millions$ 4  Millions
Nuo Therapeutics Inc   6.42 $ 1.331  Millions$ 0  Millions
Collegium Pharmaceutical Inc   6.41 $ 256.071  Millions$ 40  Millions
Veracyte Inc   6.05 $ 132.000  Millions$ 22  Millions
Kewaunee Scientific Corporation  5.98 $ 200.155  Millions$ 33  Millions
Adm Tronics Unlimited Inc   5.93 $ 1.992  Millions$ 0  Millions
Align Technology inc   5.81 $ 1,327.000  Millions$ 228  Millions
Transmedics Group Inc   5.71 $ 260.151  Millions$ 46  Millions
Opko Health Inc   5.69 $ 372.048  Millions$ 65  Millions
Avantor Inc   5.55 $ 4,447.000  Millions$ 801  Millions

Date modified: 2026-08-31T02:07:21+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.